Precise Molecular Engineering of Heptamethine Cyanine‐Based Near‐Infrared Type‐I Photosensitizers for Pro‐Death Autophagy and Hypoxia‐Tolerant Antitumor Treatment
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202504227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Fuping Han und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials, Dalian University of Technology, Dalian, 116024, China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Carbocyanines, Antineoplastic Agents, Autophagy. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Innovation Yongjiang 2035, Liaoning Binhai Laboratory.
Abstract (Originalsprache)
Heptamethine cyanine ( Cy7 ) dyes have excellent near‐infrared (NIR) fluorescence imaging capability but competitively inhibit the photodynamic therapy (PDT) effect, especially in hypoxic solid tumors. In this study, a series of aryl‐ketone‐modified Cy7 derivatives ( ACy ) were constructed to transform Cy7 into a type‐I photosensitizer capable of both hydrogen (H)‐abstraction and electron transfer for the first time. The introduction of an aryl‐ketone group at the C3 position of Cy7 imparted it with H‐abstraction capability and enhanced its intersystem crossing efficiency. Moreover, an increase in the steric hindrance of the aryl‐ketone group promoted the efficiency of the H‐abstraction reaction and electron transfer process. Optimized molecules, 3ACy‐3ipr , not only exhibited bright fluorescence but also generated hydroxyl and alkyl radicals upon NIR light irradiation. These radicals induced mitochondrial autophagy in hypoxic tumor cells, eventually leading to necrosis and ferroptosis. Tumor targeting peptide modified liposomes were used to construct nanocarriers to improve the biocompatibility and tumor retention of 3ACy‐3ipr , which fluoresces at the tumor site and significantly inhibited the growth of solid tumors via PDT. This study provides an excellent platform for the precise development and clinical utilization of NIR theranostic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals, Frontiers Science Center for Smart Materials, Dalian University of Technology, Dalian, 116024, China.
- Key Lab of Colloid and Interface Chemistry, Shandong University, Jinan, 250100, China.
- Ningbo Institute of Dalian University of Technology, Dalian University of Technology, Ningbo, 315016, China.
ORCID-Profile: Saran Long, Wen Sun, Jianjun Du, Jiangli Fan, Xiaojun Peng
Förderung
- National Natural Science Foundation of China
- Science and Technology Innovation Yongjiang 2035
- Liaoning Binhai Laboratory
- Liaoning Provincial Science and Technology Joint Fund
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Han, F., Guo, M., Zhou, X., Zhang, Z., Zhang, H., Cai, L., Li, X., Shi, T., Long, S., Sun, W., Du, J., Fan, J., & Peng, X. (2025). Precise Molecular Engineering of Heptamethine Cyanine‐Based Near‐Infrared Type‐I Photosensitizers for Pro‐Death Autophagy and Hypoxia‐Tolerant Antitumor Treatment. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202504227
Vancouver
Han F, Guo M, Zhou X, Zhang Z, Zhang H, Cai L, et al. Precise Molecular Engineering of Heptamethine Cyanine‐Based Near‐Infrared Type‐I Photosensitizers for Pro‐Death Autophagy and Hypoxia‐Tolerant Antitumor Treatment. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202504227
BibTeX
@article{Han2025,
author = {Han, Fuping and Guo, Mengya and Zhou, Xiao and Zhang, Zhenyu and Zhang, Hongyi and Cai, Lihan and Li, Xin and Shi, Tiancong and Long, Saran and Sun, Wen and Du, Jianjun and Fan, Jiangli and Peng, Xiaojun},
title = {Precise Molecular Engineering of Heptamethine Cyanine‐Based Near‐Infrared Type‐I Photosensitizers for Pro‐Death Autophagy and Hypoxia‐Tolerant Antitumor Treatment},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202504227}
}
EUVIMED